These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18347616)

  • 1. Circulating uveal melanoma cells: should we test for them?
    Fernandes BF; Belfort RN; Di Cesare S; Burnier MN
    Can J Ophthalmol; 2008 Apr; 43(2):155-8. PubMed ID: 18347616
    [No Abstract]   [Full Text] [Related]  

  • 2. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
    Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
    Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
    Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction.
    Tobal K; Sherman LS; Foss AJ; Lightman SL
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2622-5. PubMed ID: 8344785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Thiel E; Foerster MH; Keilholz U
    Oncology; 2011; 80(1-2):57-62. PubMed ID: 21625180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of tumor-associated circulating mRNA in patients with disseminated malignant melanoma.
    Rappl G; Hasselmann DO; Rössler M; Ugurel S; Tilgen W; Reinhold U
    Ann N Y Acad Sci; 2001 Sep; 945():189-91. PubMed ID: 11708477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.
    Suesskind D; Ulmer A; Schiebel U; Fierlbeck G; Spitzer B; Spitzer MS; Bartz-Schmidt KU; Grisanti S
    Acta Ophthalmol; 2011 Feb; 89(1):17-24. PubMed ID: 21272286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of tumour cells in the bloodstream of patients with uveal melanoma: influence of surgical manipulation on the dissemination of tumour cells in the bloodstream.
    Charitoudis G; Schuster R; Joussen AM; Keilholz U; Bechrakis NE
    Br J Ophthalmol; 2016 Apr; 100(4):468-72. PubMed ID: 26283704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
    Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
    Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infrequent expression of the MAGE gene family in uveal melanomas.
    Mulcahy KA; Rimoldi D; Brasseur F; Rodgers S; Liénard D; Marchand M; Rennie IG; Murray AK; McIntyre CA; Platts KE; Leyvraz S; Boon T; Rees RC
    Int J Cancer; 1996 Jun; 66(6):738-42. PubMed ID: 8647642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.
    Madic J; Piperno-Neumann S; Servois V; Rampanou A; Milder M; Trouiller B; Gentien D; Saada S; Assayag F; Thuleau A; Nemati F; Decaudin D; Bidard FC; Desjardins L; Mariani P; Lantz O; Stern MH
    Clin Cancer Res; 2012 Jul; 18(14):3934-41. PubMed ID: 22645051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
    Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic profile of uveal melanoma.
    Notting IC; Missotten GS; Sijmons B; Boonman ZF; Keunen JE; van der Pluijm G
    Curr Eye Res; 2006 Sep; 31(9):775-85. PubMed ID: 16966150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.
    Ulmer A; Beutel J; Süsskind D; Hilgers RD; Ziemssen F; Lüke M; Röcken M; Rohrbach M; Fierlbeck G; Bartz-Schmidt KU; Grisanti S
    Clin Cancer Res; 2008 Jul; 14(14):4469-74. PubMed ID: 18628461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
    van der Velden PA; Metzelaar-Blok JA; Bergman W; Monique H; Hurks H; Frants RR; Gruis NA; Jager MJ
    Cancer Res; 2001 Jul; 61(13):5303-6. PubMed ID: 11431374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytokines in uveal melanoma. Original title: uveal melanoma cytokines].
    Filer RS; Song JC; Char DH; Kaleta-Michaels S
    Klin Monbl Augenheilkd; 1993 Mar; 202(3):174-9. PubMed ID: 8510410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.
    de Vries TJ; Fourkour A; Punt CJ; Ruiter DJ; van Muijen GN
    Melanoma Res; 2000 Apr; 10(2):119-26. PubMed ID: 10803712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls in the use of rt-PCR as a prognostic indicator in melanoma.
    Wascher RA
    J Clin Oncol; 2005 Jun; 23(16):3863-4; author reply 3864-5. PubMed ID: 15923590
    [No Abstract]   [Full Text] [Related]  

  • 19. What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?
    Quaglino P; Osella-Abate S; Savoia P; Bernengo MG; Cappello N; Cavallo F
    J Clin Oncol; 2007 Mar; 25(9):1140-1; author reply 1141-2. PubMed ID: 17369579
    [No Abstract]   [Full Text] [Related]  

  • 20. Latest developments in the biology and management of uveal melanoma.
    Patel SP
    Curr Oncol Rep; 2013 Dec; 15(6):509-16. PubMed ID: 24122445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.